new and special drug
-
Vascepa® (Icosapent Ethyl) – Hypertriglyceridaemia | HongKong DengYue Medicine
-
Aixinan (Recaticimab Injection) – Hypercholesterolemia | HongKong DengYue Medicine
-
VITRAKVI (Larotrectinib) – Tumor Agnostic Therapy | HongKong DengYue Medicine
-
Youshiying (Fluocinolone Acetonide Intravitreal Implants) – NIU-PS | HongKong DengYue Medicine
-
Xofluza (Baloxavir Marboxil Tablets) – Influenza | HongKong DengYue Medicine
-
Nucala (Mepolizumab) – Eosinophil Driven | HongKong DengYue Medicine
-
Kaitanni (Cadonilimab Injection) – Oncologic immunotherapy | HongKong DengYue Medicine
-
YuTuo (Zimberelimab Injection) – cHL | HongKong DengYue Medicine
-
Orencia (Abatacept Injection) – Arthritis | HongKong DengYue Medicine
-
Yixining (Ebronucimab Injection) – Hypercholesterolemia | HongKong DengYue Medicine
-
Gazyva (Obinutuzumab) – Follicular Lymphoma | HongKong DengYue Medicine
-
Aidaro (Ebdarokimab) – Psoriasis | HongKong DengYue Medicine
-
Taiai (Telitacicept) – SLE | HongKong DengYue Medicine
-
Simponi (Golimumab) – IMIDs | HongKong DengYue Medicine
-
Esbriet (Pirfenidone) – IPF | HongKong DengYue Medicine
-
Stelara (Ustekinumab) – Immunomodulator | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights